PRJNA493121
RNA-sequencing of CD19 and CD22 Chimeric Antigen Receptor (CAR) T-cell Treated Primary Leukemia Samples
The objective of this study was to characterize the genomic profile of patients with relapsed/refractory leukemia following CAR T-cell therapy